Mirela Cernaianu

Mirela Cernaianu practices at Xcelerate Physical Therapy - Thousand Oaks in Thousand Oaks, California.

Mirela Cernaianu's NPI, 1467465120, was assigned on August 14, 2006. Mirela Cernaianu graduated from Carol Davila University of Medicine and Pharmacy in 1991. Mirela Cernaianu holds California license A79539.

Mirela Cernaianu's primary practice is Xcelerate Physical Therapy - Thousand Oaks, at 3180 Willow Ln Ste 104, Thousand Oaks, CA 91361. The practice phone is (805) 374-9900.

Mirela Cernaianu's primary practice is Xcelerate Physical Therapy - Thousand Oaks in Thousand Oaks, California. Mirela Cernaianu is also affiliated with Dignity Health - St. John's Regional Medical Center. The medical group on file is SGMF Radiology. Dmand AI also links Mirela Cernaianu to 1 more hospital, 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mirela Cernaianu practices, 5 sites in all. Vendor and product names are available with a free account.

Obstetrics and gynecology is Mirela Cernaianu's primary specialty in the NPI Registry, under taxonomy code 207V00000X. Mirela Cernaianu is board certified in board certified by the American Board of Anti-Aging / Regenerative Medicine (ABAARM). Dmand AI has Mirela Cernaianu's licenses on file in 3 states: California, Florida and Louisiana.

Dmand AI lists acute skin infection, anxiety, atrial fibrillation and flutter, chronic anemia, chronic diabetes, chronic hypertension, conjunctivitis and contact dermatitis among the conditions Mirela Cernaianu treats.

CMS data shows 3,310 Medicare services from Mirela Cernaianu across 22 procedure codes in 2024, for 132 Medicare patients. Medicare paid $105,690 for them. Every service was in an office.

CMS counts 132 Medicare patients who saw Mirela Cernaianu in 2024. The largest group is 65 to 74, with 84 patients. 64% of them have high cholesterol, and 48% have arthritis. 10% are also on Medicaid. Their average risk score is 0.81, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mirela Cernaianu's median patient age at 53, with 91% women.

In 2024, Mirela Cernaianu wrote 475 Medicare Part D claims for 81 patients. 79% of them were for generic drugs. CMS names the drug for 295 of them, across 9 drugs with 11 or more claims each, at $8,094 in total drug cost. In 2023, CMS named 211 claims across 8 drugs.

Mirela Cernaianu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mirela Cernaianu as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 12 general payments to Mirela Cernaianu from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. TherapeuticsMD, Inc. paid the most, $129.

Dmand AI lists 1 award for Mirela Cernaianu.

Mirela Cernaianu graduated from Carol Davila University of Medicine and Pharmacy in 1991. Mirela Cernaianu is a member of American Academy of Anti-Aging A4M and American College of Obstetricians and Gynecologists.

Mirela Cernaianu is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.